Multiple Sclerosis News Today3 小时
Phase 1/2 trial will test cell therapy rese-cel in relapsing, progressive MS
Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.
BBC23 小时
Radio 1 - Listen Live - BBC Sounds
Dean has Radio 1's Early Breakfast.